The Food and Drug Administration Tuesday issued a final rule that updates the definition of a custom device to include new statutory requirements and procedures.
Under the provision, custom medical devices specifically tailored to a single patient are exempt from submitting premarket approval submissions.
"[T]he exemption for manufacturers of custom devices is intended to apply only to those who are manufacturing a custom device to fit the needs of a particular patient, so the manufacturer will not be required to file a premarket notification for each particular device," the FDA said in a statement.
The agency said the updated definition of custom devices will ensure more clarity and consistency for device manufacturers.
To read the final rule and specific custom device requirements, click here.
More articles on supply chain:
FDA OKs new flu vaccine
WSJ poll: How confident are you in your supply chain?
Samsung recall sheds light on issues in large-scale supply chains